Cite
HARVARD Citation
Jakobsen, L. et al. (2020). Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients. British journal of haematology. pp. 661-671. [Online].